Search Results - Alexandre Prat

Refine Results
  1. 1

    Impact of aging on treatment considerations for multiple sclerosis patients by Gabrielle Macaron, Gabrielle Macaron, Gabrielle Macaron, Gabrielle Macaron, Catherine Larochelle, Catherine Larochelle, Catherine Larochelle, Nathalie Arbour, Nathalie Arbour, Nathalie Arbour, Manon Galmard, Jean Marc Girard, Jean Marc Girard, Jean Marc Girard, Alexandre Prat, Alexandre Prat, Alexandre Prat, Pierre Duquette, Pierre Duquette, Pierre Duquette

    Published in Frontiers in Neurology (2023-07-01)
    Get full text
    Article


  2. 2

    EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis by Hongyu Luo, Bieke Broux, Xuehai Wang, Yan Hu, Soufiane Ghannam, Wei Jin, Catherine Larochelle, Alexandre Prat, Jiangping Wu

    Published in Neurobiology of Disease (2016-07-01)
    Get full text
    Article


  3. 3

    IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening by Ina Puscas, Florian Bernard-Patrzynski, Martin Jutras, Marc-André Lécuyer, Lyne Bourbonnière, Alexandre Prat, Grégoire Leclair, V. Gaëlle Roullin

    Published in Pharmaceutics (2019-11-01)
    Get full text
    Article


  4. 4

    Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. <i>Pharmaceutics</i> 2019, <i>11</i>, 587 by Ina Puscas, Florian Bernard-Patrzynski, Martin Jutras, Marc-André Lécuyer, Lyne Bourbonnière, Alexandre Prat, Grégoire Leclair, V. Gaëlle Roullin

    Published in Pharmaceutics (2020-06-01)
    Get full text
    Article


  5. 5

    Ferroptosis induces detrimental effects in chronic EAE and its implications for progressive MS by Priya Jhelum, Stephanie Zandee, Fari Ryan, Juan G. Zarruk, Bernhard Michalke, Vivek Venkataramani, Laura Curran, Wendy Klement, Alexandre Prat, Samuel David

    Published in Acta Neuropathologica Communications (2023-07-01)
    Get full text
    Article


  6. 6

    Tau seeding in cases of multiple sclerosis by Michael S. LaCroix, Hilda Mirbaha, Ping Shang, Stephanie Zandee, Chan Foong, Alexandre Prat, Charles L. White, Olaf Stuve, Marc I. Diamond

    Published in Acta Neuropathologica Communications (2022-10-01)
    Get full text
    Article


  7. 7

    Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination by Samantha F. Kornfeld, Sarah E. Cummings, Rebecca Yaworski, Yves De Repentigny, Sabrina Gagnon, Stephanie Zandee, Samaneh Fathi, Alexandre Prat, Rashmi Kothary

    Published in Communications Biology (2024-07-01)
    Get full text
    Article


  8. 8

    Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical t... by Amel Zertal, Kanza Alami Marrouni, Kanza Alami Marrouni, Nathalie Arbour, Nathalie Arbour, Didier Jutras-Aswad, Didier Jutras-Aswad, Didier Jutras-Aswad, Marie-Pascale Pomey, Marie-Pascale Pomey, Marie-Pascale Pomey, Isabelle Rouleau, Isabelle Rouleau, Alexandre Prat, Alexandre Prat, Alexandre Prat, Catherine Larochelle, Catherine Larochelle, Catherine Larochelle, Pierre Beaulieu, Pierre Beaulieu, Pierre Beaulieu, Laury Chamelian, Laury Chamelian, Laury Chamelian, Marie-Pierre Sylvestre, Marie-Pierre Sylvestre, Danielle Morin, Jean-Sylvain Ouellette, Jean-Sylvain Ouellette, Nathalie Fréjeau, Pierre Duquette, Pierre Duquette, Pierre Duquette

    Published in Frontiers in Neurology (2024-07-01)
    Get full text
    Article


  9. 9

    Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant by Karine Moineau-Vallée, Justine Rinfret, My Hanh Luu Hoai, Valérie St-Louis, France Berthelet, Laurent Létourneau-Guillon, Émilie Lemieux-Blanchard, Alexandre Prat, Jean-Philippe Adam

    Published in Current Oncology (2020-12-01)
    Get full text
    Article


  10. 10

    Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis by Sienna S. Drake, Aliyah Zaman, Christine Gianfelice, Elizabeth M.-L. Hua, Kali Heale, Elia Afanasiev, Wendy Klement, Jo Anne Stratton, Alexandre Prat, Stephanie Zandee, Alyson E. Fournier

    Published in Journal of Neuroinflammation (2024-11-01)
    Get full text
    Article


  11. 11

    The IL‐27/IL‐27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients by Marie‐Laure Clénet, Cyril Laurent, Florent Lemaitre, Negar Farzam‐kia, Olivier Tastet, Odile Devergne, Boaz Lahav, Marc Girard, Pierre Duquette, Alexandre Prat, Catherine Larochelle, Nathalie Arbour

    Published in Clinical & Translational Immunology (2021-01-01)
    Get full text
    Article


  12. 12

    Endo-MitoEGFP mice: a novel transgenic mouse with fluorescently marked mitochondria in microvascular endothelial cells. by Sarah Pickles, Maxime Cadieux-Dion, Jorge I Alvarez, Marc-Andre Lécuyer, Sarah L Peyrard, Laurie Destroismaisons, Lydia St-Onge, Simone Terouz, Patrick Cossette, Alexandre Prat, Christine Vande Velde

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  13. 13

    The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics by Jiwon Oh, Nathalie Arbour, Fabrizio Giuliani, Melanie Guenette, Shannon Kolind, Larry Lynd, Ruth Ann Marrie, Luanne M. Metz, Alexandre Prat, Alice Schabas, Penelope Smyth, Roger Tam, Anthony Traboulsee, Voon Wee Yong, Scott B. Patten

    Get full text
    Article


  14. 14

    The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design by Jiwon Oh, Nathalie Arbour, Fabrizio Giuliani, Melanie Guenette, Shannon Kolind, Larry Lynd, Ruth Ann Marrie, Luanne M. Metz, Scott B. Patten, Alexandre Prat, Alice Schabas, Penelope Smyth, Roger Tam, Anthony Traboulsee, V. Wee Yong

    Published in BMC Neurology (2021-10-01)
    Get full text
    Article


  15. 15

    Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study by Klaus Schmierer, Heinz Wiendl, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Laura Sponton, Anita Chudecka, Lidia Gardner, Nicola De Stefano

    Get full text
    Article


  16. 16

    IL-27 shapes the immune properties of human astrocytes and their impact on encountered human T lymphocytes by Florent Lemaître, Negar Farzam-kia, Ana Carmena Moratalla, Yves Carpentier Solorio, Marie-Laure Clenet, Olivier Tastet, Aurélie Cleret-Buhot, Jean Victor Guimond, Elie Haddad, Pierre Duquette, J. Marc Girard, Alexandre Prat, Catherine Larochelle, Nathalie Arbour

    Published in Journal of Neuroinflammation (2022-09-01)
    Get full text
    Article


  17. 17

    Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosisResearch in conte... by Hanane Touil, Rui Li, Leah Zuroff, Craig S. Moore, Luke Healy, Francesca Cignarella, Laura Piccio, Samuel Ludwin, Alexandre Prat, Jennifer Gommerman, Frederick C. Bennett, Dina Jacobs, Joyce A. Benjamins, Robert P. Lisak, Jack P. Antel, Amit Bar-Or

    Published in EBioMedicine (2023-10-01)
    Get full text
    Article


  18. 18

    Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study by Heinz Wiendl, Frederik Barkhof, Xavier Montalban, Anat Achiron, Tobias Derfuss, Andrew Chan, Suzanne Hodgkinson, Alexandre Prat, Letizia Leocani, Klaus Schmierer, Finn Sellebjerg, Patrick Vermersch, Hulin Jin, Anita Chudecka, Andreas Kloetgen, Dongdong Lin, Lidia Gardner, Nicola De Stefano

    Published in Neurology and Therapy (2025-07-01)
    Get full text
    Article


  19. 19

    Cellular rejuvenation protects neurons from inflammation-mediated cell death by Sienna S. Drake, Abdulshakour Mohammadnia, Aliyah Zaman, Christine Gianfelice, Kali Heale, Adam M.R. Groh, Elizabeth M.-L. Hua, Matthew A. Hintermayer, Yuancheng Ryan Lu, David Gosselin, Stephanie Zandee, Alexandre Prat, Jo Anne Stratton, David A. Sinclair, Alyson E. Fournier

    Published in Cell Reports (2025-02-01)
    Get full text
    Article


  20. 20

    Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies by Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman

    Get full text
    Article


Search Tools: